Since its founding, Medytox has upheld fairness and transparency as the foundation of its management philosophy, working to build a healthy ecosystem for Korea's bio industry. As an industry leader, we are also focusing all our capabilities on fulfilling our social responsibility and upholding the right way of doing business.

As the global standing of K-Bio continues to rise, Medytox, a global company representing Korea's botulinum toxin industry, has further strengthened its ethics management system to meet international standards.

First, to foster an honest and transparent corporate culture, we established a dedicated ethics management organization, enacted a code of ethics, and operate an ethics reporting center, focusing on activating our internal reporting system. In addition, all employees have pledged to the 'Ethics Management Practice Statement,' clarifying our code of ethics and affirming a shared organizational goal. We also regularly run ethics management training programs and conduct systematic monitoring to ensure that a culture of voluntary compliance takes root within the company.

Ethics management is a core value of growing importance for a company's sustainable growth. As a company with world-leading competitiveness in the field of botulinum toxin, Medytox promises to continue growing as an innovative company representing K-Bio, based on the ongoing practice of ethics management and the internalization of a culture of compliance.

Thank you.